{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:10:02Z","timestamp":1751361002581,"version":"3.41.0"},"reference-count":147,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Proper antimicrobial prophylaxis is critical for reducing the risk of infection during interventional procedures. Brachytherapy, a highly effective radiation therapy for various malignancies, allows for precise radiation delivery; however, the use of foreign material as instrumentation for brachytherapy potentially increases the risk of infection. Understanding infectious complications and proper antimicrobial use in this case is essential for successful outcomes and patient safety. The aim of this review is to provide insights and summarize existing information on the infectious complications of brachytherapy in prostate, breast and gynaecological (cervical and endometrial) cancer, as well as on the potential benefit, if any, of administering antimicrobial prophylaxis. Infectious complication rates in prostate, breast and gynaecological cancer brachytherapy remain low with diverse prophylactic regimens, emphasizing the need to identify risk factors for tailored practices. The choice of the antimicrobial regimen, type of device and modality influences the probability of infectious complications. There is minimal overlap of existing brachytherapy guidelines with surgical prophylaxis guidelines. Infectious outcomes and antimicrobial resistance are underreported, and guidance for antimicrobial-resistant organisms is scarce. When indicated, prophylaxis for less than 24\u2005h is efficient. More studies oriented towards antimicrobial prophylaxis on this specific population are needed.<\/jats:p>","DOI":"10.1093\/jac\/dkaf139","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T10:23:23Z","timestamp":1747131803000},"page":"1753-1771","source":"Crossref","is-referenced-by-count":0,"title":["The role of antimicrobial prophylaxis in brachytherapy for prostate, breast and gynaecological cancer: a narrative review"],"prefix":"10.1093","volume":"80","author":[{"given":"Konstantinos","family":"Alexakis","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, German Medical Institute , Limassol ,","place":["Cyprus"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iosif","family":"Strouthos","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, German Medical Institute , Limassol ,","place":["Cyprus"]},{"name":"School of Medicine, European University Cyprus , Nicosia ,","place":["Cyprus"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris P","family":"Agouridis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, German Medical Institute , Limassol ,","place":["Cyprus"]},{"name":"School of Medicine, European University Cyprus , Nicosia ,","place":["Cyprus"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Ferentinos","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, German Medical Institute , Limassol ,","place":["Cyprus"]},{"name":"School of Medicine, European University Cyprus , Nicosia ,","place":["Cyprus"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos","family":"Zamboglou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, German Medical Institute , Limassol ,","place":["Cyprus"]},{"name":"School of Medicine, European University Cyprus , Nicosia ,","place":["Cyprus"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-8535","authenticated-orcid":false,"given":"Nikolaos","family":"Spernovasilis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, German Medical Institute , Limassol ,","place":["Cyprus"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2025070104563383500_dkaf139-B1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nyas.12468","article-title":"Finding alternatives to antibiotics","volume":"1323","author":"Allen","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"2025070104563383500_dkaf139-B2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1086\/657912","article-title":"Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs","volume":"32","author":"Umscheid","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025070104563383500_dkaf139-B3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3389\/fphar.2018.00776","article-title":"Prevention of surgical site infections: a systematic review of cost analyses in the use of prophylactic antibiotics","volume":"9","author":"Purba","year":"2018","journal-title":"Front Pharmacol"},{"key":"2025070104563383500_dkaf139-B4","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.2106\/JBJS.RVW.24.00068","article-title":"Extended postoperative antibiotic prophylaxis is associated with no clinical value and higher projected cost following adult spinal surgery: a stratified meta-analysis and probability-based cost projections","volume":"12","author":"Awad","year":"2024","journal-title":"JBJS Rev"},{"key":"2025070104563383500_dkaf139-B5","doi-asserted-by":"publisher","first-page":"e0179117","DOI":"10.1371\/journal.pone.0179117","article-title":"Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile","volume":"12","author":"Balch","year":"2017","journal-title":"PLoS One"},{"key":"2025070104563383500_dkaf139-B6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/jamasurg.2019.0569","article-title":"Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events","volume":"154","author":"Branch-Elliman","year":"2019","journal-title":"JAMA Surg"},{"key":"2025070104563383500_dkaf139-B7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.5114\/jcb.2017.72607","article-title":"Current status of brachytherapy in cancer treatment\u2014short overview","volume":"9","author":"Skowronek","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B8","first-page":"197","article-title":"Use of prophylactic antibiotics in patients with carcinoma of the cervix receiving intracavitary radium insertion","volume":"14","author":"To","year":"1993","journal-title":"Eur J Gynaecol Oncol"},{"key":"2025070104563383500_dkaf139-B9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s10156-013-0610-0","article-title":"Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy: multicenter cohort study","volume":"19","author":"Taoka","year":"2013","journal-title":"J Infect Chemother"},{"key":"2025070104563383500_dkaf139-B10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10156-013-0631-8","article-title":"Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter study","volume":"19","author":"Togo","year":"2013","journal-title":"J Infect Chemother"},{"key":"2025070104563383500_dkaf139-B11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0360-3016(96)00296-9","article-title":"Low risk of perioperative infection without prophylactic antibiotics for transperineal prostate brachytherapy","volume":"36","author":"Wallner","year":"1996","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.urology.2003.09.021","article-title":"Epididymitis after prostate brachytherapy","volume":"63","author":"Hoffelt","year":"2004","journal-title":"Urology"},{"key":"2025070104563383500_dkaf139-B13","first-page":"104","article-title":"Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy?","volume":"6","author":"Dicker","year":"2000","journal-title":"Tech Urol"},{"key":"2025070104563383500_dkaf139-B14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11604-012-0053-z","article-title":"Efficacy of prophylactic single-dose therapy using fluoroquinolone for prostate brachytherapy","volume":"30","author":"Nomura","year":"2012","journal-title":"Jpn J Radiol"},{"key":"2025070104563383500_dkaf139-B15","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1245\/s10434-014-3528-6","article-title":"Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation","volume":"21","author":"Haynes","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2025070104563383500_dkaf139-B16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jrr\/rrae018","article-title":"Are prophylactic antibiotics required for combined intracavitary and interstitial brachytherapy of gynecologic cancers?","volume":"65","author":"Kumazawa","year":"2024","journal-title":"J Radiat Res"},{"key":"2025070104563383500_dkaf139-B17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2025070104563383500_dkaf139-B18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025070104563383500_dkaf139-B19","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"2025070104563383500_dkaf139-B20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","article-title":"Time trends and local variation in primary treatment of localized prostate cancer","volume":"28","author":"Cooperberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"2025070104563383500_dkaf139-B21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","article-title":"American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer","volume":"44","author":"Nag","year":"1999","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5114\/jcb.2024.135630","article-title":"Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age","volume":"16","author":"Armstrong","year":"2024","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.clon.2023.01.006","article-title":"Long-term biochemical control of a prospective cohort of prostate cancer patients treated with interstitial brachytherapy versus radical prostatectomy","volume":"35","author":"Sanmamed","year":"2023","journal-title":"Clin Oncol"},{"key":"2025070104563383500_dkaf139-B24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bju.12358","article-title":"Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK","volume":"113","author":"Dickinson","year":"2014","journal-title":"BJU Int"},{"key":"2025070104563383500_dkaf139-B25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.brachy.2024.01.010","article-title":"Brachytherapy for favorable prognostic prostate cancer in men up to 60\u2005years of age: long term follow-up","volume":"23","author":"Jacques","year":"2024","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijrobp.2023.11.011","article-title":"Timing of high-dose-rate brachytherapy with external beam radiation therapy in patients with intermediate- and high-risk localized prostate cancer and its effects on toxicity and quality of life: a randomized controlled trial (THEPCA)","volume":"119","author":"Choudhury","year":"2024","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00345-006-0083-1","article-title":"Long-term results of interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer","volume":"24","author":"Machtens","year":"2006","journal-title":"World J Urol"},{"key":"2025070104563383500_dkaf139-B28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ijrobp.2010.05.042","article-title":"Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I125 prostate brachytherapy in clinically localized prostate cancer: Seattle experience","volume":"81","author":"Sylvester","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B29","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.juro.2008.03.133","article-title":"12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"179","author":"Potters","year":"2008","journal-title":"J Urol"},{"key":"2025070104563383500_dkaf139-B30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5114\/jcb.2024.139278","article-title":"Acute toxicity outcomes from salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after prior radiotherapy","volume":"16","author":"Fang","year":"2024","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00066-024-02222-w","article-title":"Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients","volume":"200","author":"Moll","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"2025070104563383500_dkaf139-B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2340\/sju.v58.11920","article-title":"Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study","volume":"58","author":"Holmbom","year":"2023","journal-title":"Scand J Urol"},{"key":"2025070104563383500_dkaf139-B33","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1007\/s00345-020-03454-y","article-title":"Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy","volume":"39","author":"Ding","year":"2021","journal-title":"World J Urol"},{"key":"2025070104563383500_dkaf139-B34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urology.2019.12.023","article-title":"Risk factors for infection after prostate biopsy in the United States","volume":"138","author":"Shoag","year":"2020","journal-title":"Urology"},{"key":"2025070104563383500_dkaf139-B35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.prnil.2018.03.003","article-title":"Thirty-day hospital revisits after prostate brachytherapy: who is at risk?","volume":"7","author":"Li","year":"2019","journal-title":"Prostate Int"},{"key":"2025070104563383500_dkaf139-B36","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0360-3016(99)00281-3","article-title":"Prostate brachytherapy in patients with prior evidence of prostatitis","volume":"45","author":"Aggarwal","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025070104563383500_dkaf139-B37","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3390\/cancers16081549","article-title":"Prostate tissue microbiome in patients with prostate cancer: a systematic review","volume":"16","author":"Ward Grados","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2025070104563383500_dkaf139-B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.prnil.2022.03.004","article-title":"Prostate diseases and microbiome in the prostate, gut, and urine","volume":"10","author":"Miyake","year":"2022","journal-title":"Prostate Int"},{"key":"2025070104563383500_dkaf139-B39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/iju5.12579","article-title":"Seed lost to perineum from hydrogel spacer after brachytherapy for prostate cancer","volume":"6","author":"Nakiri","year":"2023","journal-title":"IJU Case Rep"},{"key":"2025070104563383500_dkaf139-B40","doi-asserted-by":"publisher","first-page":"e235903","DOI":"10.1136\/bcr-2020-235903","article-title":"Unusual cause of Fournier\u2019s gangrene: colorectal-genitourinary tract fistulae status post brachytherapy","volume":"13","author":"Saleem","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2025070104563383500_dkaf139-B41","doi-asserted-by":"publisher","first-page":"e51050","DOI":"10.7759\/cureus.51050","article-title":"Perineal abscess following SpaceOAR insertion","volume":"15","author":"Azhar","year":"2023","journal-title":"Cureus"},{"key":"2025070104563383500_dkaf139-B42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.urology.2023.09.016","article-title":"Real-world complications of the SpaceOAR hydrogel spacer: a review of the manufacturer and user facility device experience database","volume":"183","author":"Fernandez","year":"2024","journal-title":"Urology"},{"key":"2025070104563383500_dkaf139-B43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1089\/end.2019.0431","article-title":"Major complications and adverse events related to the injection of the SpaceOAR hydrogel system before radiotherapy for prostate cancer: review of the manufacturer and user facility device experience database","volume":"33","author":"Aminsharifi","year":"2019","journal-title":"J Endourol"},{"key":"2025070104563383500_dkaf139-B44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12894-020-00767-3","article-title":"The use of hyperbaric oxygen to treat actinic rectal fistula after SpaceOAR use and radiotherapy for prostate cancer: a case report","volume":"20","author":"Kashihara","year":"2020","journal-title":"BMC Urol"},{"key":"2025070104563383500_dkaf139-B45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.radonc.2014.02.011","article-title":"A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy\u200a \u00b1 \u200aintensity modulated radiation therapy","volume":"111","author":"Strom","year":"2014","journal-title":"Radiother Oncol"},{"key":"2025070104563383500_dkaf139-B46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.brachy.2015.12.007","article-title":"Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy","volume":"15","author":"Yeh","year":"2016","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.brachy.2017.10.014","article-title":"Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy","volume":"17","author":"Wu","year":"2018","journal-title":"Brachytherapy"},{"volume-title":"EAU guidelines.","year":"2024","author":"European Association of Urology","key":"2025070104563383500_dkaf139-B48"},{"key":"2025070104563383500_dkaf139-B49","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0022-5347(17)50580-7","article-title":"Prophylactic antibiotics and foley catheter use in transperineal needle biopsy of the prostate","volume":"131","author":"Packer","year":"1984","journal-title":"J Urol"},{"key":"2025070104563383500_dkaf139-B50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10156-010-0103-3","article-title":"A single-dose regimen for antimicrobial prophylaxis to prevent perioperative infection in urological clean and clean-contaminated surgery","volume":"17","author":"Higuchi","year":"2011","journal-title":"J Infect Chemother"},{"key":"2025070104563383500_dkaf139-B51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.canrad.2022.10.005","article-title":"Infection after prostatic transrectal fiducial marker implantation for image guided radiation therapy","volume":"27","author":"Reynaud","year":"2023","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"2025070104563383500_dkaf139-B52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/jrr\/rrac011","article-title":"Japanese Society for Radiation Oncology Consensus Guidelines of combined intracavitary and interstitial brachytherapy for gynecological cancers","volume":"63","author":"Murakami","year":"2022","journal-title":"J Radiat Res"},{"key":"2025070104563383500_dkaf139-B53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5173\/ceju.2022.0109","article-title":"Preliminary trial of 24 vs 72 hour perioperative meropenem in patients with ESBL-producing Enterobacterales bacteriuria scheduled for urological procedures","volume":"75","author":"Radko","year":"2022","journal-title":"Cent European J Urol"},{"key":"2025070104563383500_dkaf139-B54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/JU.0000000000000509","article-title":"Best practice statement on urologic procedures and antimicrobial prophylaxis","volume":"203","author":"Lightner","year":"2020","journal-title":"J Urol"},{"key":"2025070104563383500_dkaf139-B55","doi-asserted-by":"publisher","first-page":"e7046","DOI":"10.7759\/cureus.7046","article-title":"A rare case of prostatic and bilateral renal abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus infection","volume":"12","author":"Vyas","year":"2020","journal-title":"Cureus"},{"key":"2025070104563383500_dkaf139-B56","doi-asserted-by":"publisher","first-page":"ofz372","DOI":"10.1093\/ofid\/ofz372","article-title":"Clinical characteristics and outcome of Staphylococcus aureus prostate abscess from ten years of experience at a tertiary care center","volume":"6","author":"Walker","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025070104563383500_dkaf139-B57","doi-asserted-by":"publisher","first-page":"ofab503","DOI":"10.1093\/ofid\/ofab503","article-title":"The changing epidemiology and microbiology of patients with prostate abscess: increase in staphylococcal infection","volume":"8","author":"McCormick","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025070104563383500_dkaf139-B58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/JU.0000000000002251","article-title":"Infection rate after transperineal prostate biopsy with and without prophylactic antibiotics: results from a systematic review and meta-analysis of comparative studies","volume":"207","author":"Castellani","year":"2022","journal-title":"J Urol"},{"key":"2025070104563383500_dkaf139-B59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.euros.2022.01.001","article-title":"Role of prophylactic antibiotics in transperineal prostate biopsy: a systematic review and meta-analysis","volume":"37","author":"Basourakos","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"2025070104563383500_dkaf139-B60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17650\/17269776-2021-17-2-46-52","article-title":"The first experience of transperineal prostate biopsy without antibiotic prophylaxis","volume":"17","author":"Chernysheva","year":"2021","journal-title":"Cancer Urol"},{"key":"2025070104563383500_dkaf139-B61","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S1473-3099(22)00373-5","article-title":"Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial","volume":"22","author":"Jacewicz","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025070104563383500_dkaf139-B62","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/iju.13161","article-title":"Essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition","volume":"23","author":"Yamamoto","year":"2016","journal-title":"Int J Urol"},{"key":"2025070104563383500_dkaf139-B63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"2025070104563383500_dkaf139-B64","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1007\/s00330-019-06505-0","article-title":"MRI targeted single fraction HDR brachytherapy for localized prostate carcinoma: a feasibility study of focal radiation therapy (ProFocAL)","volume":"30","author":"Fischbach","year":"2020","journal-title":"Eur Radiol"},{"key":"2025070104563383500_dkaf139-B65","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.brachy.2024.06.001","article-title":"Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer","volume":"23","author":"Lee","year":"2024","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B66","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/00000658-193710000-00012","article-title":"The place of radium in the treatment of cancer of the breast","volume":"106","author":"Keynes","year":"1937","journal-title":"Ann Surg"},{"key":"2025070104563383500_dkaf139-B67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","article-title":"5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"key":"2025070104563383500_dkaf139-B68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","article-title":"Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial","volume":"18","author":"Polg\u00e1r","year":"2017","journal-title":"Lancet Oncol"},{"key":"2025070104563383500_dkaf139-B69","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ijrobp.2020.11.006","article-title":"Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study","volume":"109","author":"Polg\u00e1r","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B70","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1470-2045(23)00018-9","article-title":"Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial","volume":"24","author":"Strnad","year":"2023","journal-title":"Lancet Oncol"},{"key":"2025070104563383500_dkaf139-B71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2016.06.019","article-title":"GEC-ESTRO multicenter phase 3-trial: accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: early toxicity and patient compliance","volume":"120","author":"Ott","year":"2016","journal-title":"Radiother Oncol"},{"key":"2025070104563383500_dkaf139-B72","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.brachy.2017.11.008","article-title":"Accelerated partial breast irradiation for suitable elderly women using a single fraction of multicatheter interstitial high-dose-rate brachytherapy: early results of the Single-Fraction Elderly Breast Irradiation (SiFEBI) phase I\/II trial","volume":"17","author":"Hannoun-L\u00e9vi","year":"2018","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B73","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","article-title":"The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation","volume":"17","author":"Shah","year":"2018","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B74","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijrobp.2007.09.046","article-title":"Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results","volume":"71","author":"Cuttino","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B75","first-page":"355","article-title":"Treatment results of MammoSite catheter in combination with whole-breast irradiation","volume":"36","author":"Gitt","year":"2016","journal-title":"Anticancer Res"},{"key":"2025070104563383500_dkaf139-B76","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1245\/ASO.2004.02.009","article-title":"Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer","volume":"11","author":"Richards","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"2025070104563383500_dkaf139-B77","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/archsurg.140.8.787","article-title":"Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience","volume":"140","author":"DiFronzo","year":"2005","journal-title":"Arch Surg"},{"key":"2025070104563383500_dkaf139-B78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijrobp.2007.02.026","article-title":"Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont Hospital experience","volume":"69","author":"Chao","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B79","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1075-122X.2005.00014.x","article-title":"Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator","volume":"11","author":"Dickler","year":"2005","journal-title":"Breast J"},{"key":"2025070104563383500_dkaf139-B80","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.amjsurg.2005.06.007","article-title":"Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial","volume":"190","author":"Zannis","year":"2005","journal-title":"Am J Surg"},{"key":"2025070104563383500_dkaf139-B81","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/cncr.21681","article-title":"Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma","volume":"106","author":"Chen","year":"2006","journal-title":"Cancer"},{"key":"2025070104563383500_dkaf139-B82","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1245\/s10434-013-3158-4","article-title":"Treatment efficacy with Accelerated Partial Breast Irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite\u00ae breast brachytherapy registry trial","volume":"20","author":"Shah","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2025070104563383500_dkaf139-B83","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/cncr.21289","article-title":"First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial","volume":"104","author":"Vicini","year":"2005","journal-title":"Cancer"},{"key":"2025070104563383500_dkaf139-B84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5114\/jcb.2012.27946","article-title":"Acute toxicity and early cosmetic outcome in patients treated with multicatheter balloon brachytherapy with skin spacing \u2264 7.0 millimeters","volume":"4","author":"Lee","year":"2012","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B85","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ijrobp.2009.05.043","article-title":"Phase I\/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the MammoSite balloon breast brachytherapy catheter using a 2-day dose schedule","volume":"77","author":"Wallace","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B86","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0360-3016(02)04277-3","article-title":"Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy","volume":"55","author":"Keisch","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025070104563383500_dkaf139-B87","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/(sici)1096-9098(199708)65:4&lt;263::aid-jso7&gt;3.0.co;2-3","article-title":"Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study","volume":"65","author":"Perera","year":"1997","journal-title":"J Surg Oncol"},{"key":"2025070104563383500_dkaf139-B88","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.radonc.2006.08.028","article-title":"Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German\u2013Austrian multi-centre trial","volume":"82","author":"Ott","year":"2007","journal-title":"Radiother Oncol"},{"key":"2025070104563383500_dkaf139-B89","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00066-004-1294-2","article-title":"Accelerated partial breast irradiation with iridium-192 multicatheter PDR\/HDR brachytherapy: preliminary results of the German-Austrian multicenter trial","volume":"180","author":"Ott","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"2025070104563383500_dkaf139-B90","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.brachy.2018.08.012","article-title":"Accelerated partial breast irradiation with perioperative multicatheter interstitial brachytherapy\u2014a feasibility study","volume":"17","author":"Pohankov\u00e1","year":"2018","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B91","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/JCMA.0000000000000893","article-title":"Preliminary outcomes of accelerated partial breast irradiation by interstitial multicatheter brachytherapy with intraoperative free-hand catheter implantation in early breast cancer","volume":"86","author":"Cheng","year":"2023","journal-title":"J Chin Med Assoc"},{"key":"2025070104563383500_dkaf139-B92","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.amjsurg.2004.06.027","article-title":"Surgical considerations in the treatment of early stage breast cancer with accelerated partial breast irradiation (APBI) in breast conserving therapy via interstitial brachytherapy","volume":"188","author":"Benitez","year":"2004","journal-title":"Am J Surg"},{"key":"2025070104563383500_dkaf139-B93","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5114\/jcb.2018.75594","article-title":"Advantages of intraoperative implant for interstitial brachytherapy for accelerated partial breast irradiation either in frail patients with early-stage disease or in locally recurrent breast cancer","volume":"10","author":"Cozzi","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B94","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijrobp.2006.12.014","article-title":"Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up","volume":"68","author":"Dragun","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B95","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/COC.0b013e3181b20426","article-title":"Breast conserving surgery and accelerated partial breast irradiation after prior breast radiation therapy","volume":"33","author":"Adkison","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"2025070104563383500_dkaf139-B96","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brachy.2007.10.006","article-title":"The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer","volume":"7","author":"Chadha","year":"2008","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/jcb.2023.125579","article-title":"HDR-brachytherapy for accelerated partial breast irradiation: long-term experience from a Japanese institution","volume":"15","author":"Yoshida","year":"2023","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B98","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12282-008-0067-7","article-title":"Preliminary result of accelerated partial breast irradiation after breast-conserving surgery","volume":"16","author":"Yoshida","year":"2009","journal-title":"Breast Cancer"},{"key":"2025070104563383500_dkaf139-B99","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.brachy.2008.07.001","article-title":"Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy","volume":"7","author":"Watkins","year":"2008","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B100","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brachy.2008.07.005","article-title":"MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2\u2005years of followup","volume":"8","author":"Haley","year":"2009","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B101","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brachy.2009.08.010","article-title":"Intraoperative placement of MammoSite for breast brachytherapy treatment and seroma incidence","volume":"9","author":"Ravi","year":"2010","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B102","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijrobp.2005.12.045","article-title":"Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors","volume":"65","author":"Evans","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2018.12.025","article-title":"Three-fraction intracavitary accelerated partial breast brachytherapy: early provider and patient-reported outcomes of a novel regimen","volume":"104","author":"Jethwa","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B104","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.brachy.2014.05.017","article-title":"Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence","volume":"13","author":"Trombetta","year":"2014","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B105","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ijrobp.2015.12.013","article-title":"Contemporary toxicity profile of breast brachytherapy versus external beam radiation after lumpectomy for breast cancer","volume":"94","author":"Huo","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B106","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.breast.2015.09.004","article-title":"Comparison of chronic toxicities between brachytherapy-based accelerated partial breast irradiation and whole breast irradiation using intensity modulated radiotherapy","volume":"24","author":"Wobb","year":"2015","journal-title":"The Breast"},{"key":"2025070104563383500_dkaf139-B107","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: interstitial multi-catheter breast brachytherapy as accelerated partial breast irradiation alone or as boost\u2014GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"author":"American Society of Breast Surgeons","key":"2025070104563383500_dkaf139-B108"},{"key":"2025070104563383500_dkaf139-B109","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.rpor.2020.05.004","article-title":"Consensus statement from the Spanish Brachytherapy Group (GEB) on accelerated partial breast irradiation using multicatheter interstitial brachytherapy","volume":"25","author":"P\u00e9rez-Echag\u00fcen","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"2025070104563383500_dkaf139-B110","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0360-3016(01)01547-4","article-title":"The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy","volume":"50","author":"Baglan","year":"2001","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B111","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archsurg.139.6.603","article-title":"Early experience with balloon brachytherapy for breast cancer","volume":"139","author":"Dowlatshahi","year":"2004","journal-title":"Arch Surg"},{"key":"2025070104563383500_dkaf139-B112","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brachy.2004.08.003","article-title":"Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial","volume":"3","author":"Strnad","year":"2004","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B113","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijrobp.2018.12.050","article-title":"Three-fraction Accelerated Partial Breast Irradiation (APBI) delivered with brachytherapy applicators is feasible and safe: first results from the TRIUMPH-T trial","volume":"104","author":"Khan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025070104563383500_dkaf139-B114","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ijrobp.2011.09.003","article-title":"Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial","volume":"83","author":"Hattangadi","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B115","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1245\/s10434-011-2133-1","article-title":"Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial","volume":"19","author":"Khan","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2025070104563383500_dkaf139-B116","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.2147\/OTT.S106758","article-title":"Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program","volume":"9","author":"Koh","year":"2016","journal-title":"OncoTargets Ther"},{"key":"2025070104563383500_dkaf139-B117","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.radonc.2017.07.015","article-title":"Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study","volume":"124","author":"Aristei","year":"2017","journal-title":"Radiother Oncol"},{"key":"2025070104563383500_dkaf139-B118","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B119","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group\u22c6 (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"2025070104563383500_dkaf139-B120","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/gyno.1999.5627","article-title":"Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma","volume":"76","author":"Wollschlaeger","year":"2000","journal-title":"Gynecol Oncol"},{"key":"2025070104563383500_dkaf139-B121","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0360-3016(99)00545-3","article-title":"Perioperative and postoperative complications of intracavitary radiation for FIGO stage I\u2013III carcinoma of the cervix","volume":"46","author":"Jhingran","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B122","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0360-3016(94)90390-5","article-title":"Perioperative morbidity of intracavitary gynecologic brachytherapy","volume":"29","author":"Lanciano","year":"1994","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B123","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/0360-3016(84)90234-7","article-title":"Temperature elevation during brachytherapy for carcinoma of the uterine cervix: adverse effect on survival and enhancement of distant metastasis","volume":"10","author":"Kapp","year":"1984","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B124","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0360-3016(98)00349-6","article-title":"Perioperative morbidity and mortality of high-dose-rate gynecologic brachytherapy","volume":"42","author":"Petereit","year":"1998","journal-title":"Int J Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B125","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1006\/gyno.1996.4564","article-title":"Intra- and perioperative complications associated with tandem and colpostat application for cervix cancer","volume":"64","author":"Corn","year":"1997","journal-title":"Gynecol Oncol"},{"key":"2025070104563383500_dkaf139-B126","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ygyno.2018.10.011","article-title":"Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: a systematic review and meta-analysis","volume":"151","author":"Sapienza","year":"2018","journal-title":"Gynecol Oncol"},{"key":"2025070104563383500_dkaf139-B127","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5114\/jcb.2014.45493","article-title":"Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer","volume":"6","author":"Gupta","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B128","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2478\/raon-2013-0030","article-title":"Uterine perforation\u20145-year experience in 3-D image guided gynaecological brachytherapy at Institute of Oncology, Ljubljana","volume":"47","author":"Segedin","year":"2013","journal-title":"Radiol Oncol"},{"key":"2025070104563383500_dkaf139-B129","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.brachy.2021.02.001","article-title":"Uterine perforation during brachytherapy for cervical cancer: complications, outcomes, and best practices for forward treatment planning and management","volume":"20","author":"Small","year":"2021","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B130","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.gore.2021.100799","article-title":"Meningitis caused by Listeria monocytogenes in a locally advanced cervical cancer patient with pyometra: a case report","volume":"37","author":"Matoba","year":"2021","journal-title":"Gynecol Oncol Rep"},{"key":"2025070104563383500_dkaf139-B131","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5114\/jcb.2023.134169","article-title":"Clinical outcomes of single application multi-fractionated CT-guided interstitial high-dose-rate brachytherapy for locally advanced cervical cancer: a multi-institution initial experience","volume":"15","author":"Yap","year":"2023","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B132","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13014-023-02237-0","article-title":"The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study","volume":"18","author":"Song","year":"2023","journal-title":"Radiat Oncol"},{"key":"2025070104563383500_dkaf139-B133","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s12094-022-03016-1","article-title":"Recommendations of the Spanish brachytherapy group of the Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics for interstitial high-dose-rate brachytherapy for gynaecologic malignancies","volume":"25","author":"Guti\u00e9rrez Migu\u00e9lez","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"2025070104563383500_dkaf139-B134","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B135","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.brachy.2015.06.002","article-title":"Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer","volume":"14","author":"Schwarz","year":"2015","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B136","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5114\/jcb.2019.87406","article-title":"Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy","volume":"11","author":"Mahantshetty","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B137","doi-asserted-by":"publisher","first-page":"e0161242","DOI":"10.1371\/journal.pone.0161242","article-title":"Effect of predatory bacteria on human cell lines","volume":"11","author":"Gupta","year":"2016","journal-title":"PLoS One"},{"key":"2025070104563383500_dkaf139-B138","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5114\/jcb.2017.68767","article-title":"Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy","volume":"9","author":"Nielsen","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"2025070104563383500_dkaf139-B139","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.radonc.2017.03.005","article-title":"Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: a systematic review of technique, local control and toxicities","volume":"123","author":"Mendez","year":"2017","journal-title":"Radiother Oncol"},{"key":"2025070104563383500_dkaf139-B140","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.brachy.2018.05.009","article-title":"Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: clinical feasibility and initial results","volume":"17","author":"Walter","year":"2018","journal-title":"Brachytherapy"},{"key":"2025070104563383500_dkaf139-B141","doi-asserted-by":"publisher","first-page":"677052","DOI":"10.3389\/fonc.2021.677052","article-title":"Analysis of applicator insertion related acute side effects for cervical cancer treated with brachytherapy","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"2025070104563383500_dkaf139-B142","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017","volume":"152","author":"Berr\u00edos-Torres","year":"2017","journal-title":"JAMA Surg"},{"volume-title":"Systematic review and evidence-based guidance on perioperative antibiotic prophylaxis","year":"2013","author":"European Centre for Disease Prevention and Control","key":"2025070104563383500_dkaf139-B143"},{"key":"2025070104563383500_dkaf139-B144","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jamcollsurg.2016.10.029","article-title":"American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update","volume":"224","author":"Ban","year":"2017","journal-title":"J Am Coll Surg"},{"key":"2025070104563383500_dkaf139-B145","volume-title":"Global Guidelines for the Prevention of Surgical Site Infection,","author":"World Health Organization","year":"2018","edition":"2nd edn"},{"key":"2025070104563383500_dkaf139-B146","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1017\/ice.2023.67","article-title":"Strategies to prevent surgical site infections in acute-care hospitals: 2022 update","volume":"44","author":"Calderwood","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025070104563383500_dkaf139-B147","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmi.2022.12.012","article-title":"ESCMID\/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant gram-negative bacteria before surgery","volume":"29","author":"Righi","year":"2023","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/7\/1753\/63163737\/dkaf139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/7\/1753\/63163737\/dkaf139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:56:39Z","timestamp":1751360199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/7\/1753\/8129395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":147,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,5,13]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf139","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,13]]}}}